Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Athenex
Biotech
The 2023 Biotech Graveyard
Nearly four times as many companies entered the biotech graveyard in 2023 compared to 2022.
Max Bayer
,
Gabrielle Masson
Oct 31, 2023 6:00am
Athenex files for bankruptcy, seeks buyer for cell therapy unit
May 15, 2023 10:47am
BMS CEO set to leave after 8-year run—Chutes & Ladders
Apr 28, 2023 9:30am
Athenex's cash dries up as it faces clinical hold, creditors
Mar 20, 2023 12:00pm
Forte taps new exec amid shareholder dissent—Chutes & Ladders
Jun 10, 2022 9:30am
Layoff 'wave' not letting up amid oversaturation of biotechs
Mar 28, 2022 10:05am
